eFFECTOR Therapeutics, Inc. Warrant
EFTRW
EFTRW was delisted on the 2nd of July, 2024.
12 hedge funds and large institutions have $326K invested in eFFECTOR Therapeutics, Inc. Warrant in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
0% more funds holding
Funds holding: 12 → 12 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
39% less capital invested
Capital invested by funds: $534K → $326K (-$208K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$2.93K |
| 2 |
JFG
Jefferies Financial Group
New York
|
+$1.39K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$444 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$10K |
| 2 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$2.39K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Aristeia Capital
Greenwich,
Connecticut
| $174K | -$2.39K | -17,177 | -1% |
|
2
Goldman Sachs
New York
| $48.9K | – | – | – |
|
|
WA
3
Whitebox Advisors
Minneapolis,
Minnesota
| $48.8K | – | – | – |
|
|
MI
4
MMCAP International
Grand Cayman,
Cayman Islands
| $23.9K | – | – | – |
|
|
ECM
5
Evolution Capital Management
Crystal Bay,
Nevada
| $8.19K | – | – | – |
|
|
TCM
6
Tenor Capital Management
New York
| $5.46K | – | – | – |
|
|
PA
7
Parallel Advisors
San Francisco,
California
| $4.97K | – | – | – |
|
|
ICM
8
III Capital Management
Boca Raton,
Florida
| $4K | – | – | – |
|
|
9
Citadel Advisors
Miami,
Florida
| $3.44K | +$2.93K | +21,033 | New |
|
|
WAM
10
Wolverine Asset Management
Chicago,
Illinois
| $2.54K | +$444 | +3,190 | +26% |
|
|
JFG
11
Jefferies Financial Group
New York
| $1.64K | +$1.39K | +10,000 | New |
|
|
CH
12
CVI Holdings
Wilmington,
Delaware
| – | -$10K | -49,738 | Closed |
|
EFTRW Hedge Fund Activity: Q4 2022 in Review
12 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in eFFECTOR Therapeutics, Inc. Warrant (EFTRW) for Q4 2022, worth a combined $326K — down 39% from $534K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new EFTRW positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $2.93K. The largest seller was CVI Holdings, exiting entirely with an estimated $10K sold.
- 12 institutional investors held eFFECTOR Therapeutics, Inc. Warrant (EFTRW) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $326K of eFFECTOR Therapeutics, Inc. Warrant stock for Q4 2022, down 39% quarter-over-quarter.
- 2 funds opened new eFFECTOR Therapeutics, Inc. Warrant positions in Q4 2022 and 1 closed out, a net change of +1 holder.
- The largest eFFECTOR Therapeutics, Inc. Warrant buyer in Q4 2022 was Citadel Advisors, an estimated $2.93K added.
- The largest eFFECTOR Therapeutics, Inc. Warrant seller in Q4 2022 was CVI Holdings, an estimated $10K sold.
Based on aggregated 13F filings for Q4 2022.